Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: Case report in a child

Wang, 2003, Severe bacterial infection in transfusion-dependent patients with thalassemia major, Clin Infect Dis, 37, 984, 10.1086/378062 Miron, 2003, Vibrio vulnificus necrotizing fasciitis of the calf presenting with compartment syndrome, Pediatr Infect Dis J, 22, 666, 10.1097/01.inf.0000076546.27263.15 Chiu, 2002, Necrotising fasciitis caused by Vibrio vulnificus in a child without known risk factors, Eur J Pediatr, 161, 464, 10.1007/s00431-002-0975-z Woo, 1984, Necrotising fasciitis caused by Vibrio vulnificus, J Clin Pathol, 37, 1301, 10.1136/jcp.37.11.1301 Wang, 2000, Vibrio vulnificus infection complicated by acute respiratory distress syndrome in a child with nephrotic syndrome, Pediatr Pulmonol, 29, 400, 10.1002/(SICI)1099-0496(200005)29:5<400::AID-PPUL10>3.0.CO;2-J Chen, 2012, Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period, J Antimicrob Chemother, 67, 488, 10.1093/jac/dkr476 Liu, 2008, In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan, Antimicrob Agents Chemother, 52, 2677, 10.1128/AAC.00002-08 Reygaert, 2010, Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline, Ther Clin Risk Manag, 6, 419, 10.2147/TCRM.S9117 Oberholzer, 2001, Sepsis syndromes: understanding the role of innate and acquired immunity, Shock, 16, 83, 10.1097/00024382-200116020-00001 Kloppenburg, 1996, The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes, Antimicrob Agents Chemother, 40, 934, 10.1128/AAC.40.4.934 Chiang, 2007, Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection, J Microbiol Immunol Infect, 40, 123 Saliba, 2009, Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines, Immunopharmacol Immunotoxicol, 31, 583, 10.3109/08923970902838672